<DOC>
	<DOCNO>NCT02966574</DOCNO>
	<brief_summary>Whole-body MRI include diffusion booming technique . Numerous study demonstrate interest metastatic cancer . Breast cancer , especially hormone-sensitive one , osteophilic bone frequent metastatic site . Apart morphological criterion ( lesion size RECIST criterion ) , MRI provide quantitative functional criterion ( diffusion ADC value ) . According recent study , whole body MRI good PET/CT effective bone scintigraphy diagnosis bone metastases cancer breast prostate high metastatic risk . Therefore , seem appropriate study performance whole body MRI pre-therapeutic assessment breast cancer high risk metastasis monitoring metastatic breast cancer .</brief_summary>
	<brief_title>Magnetic Resonance Imaging Whole Body , Including Diffusion , Medical Evaluation Breast Cancers High Risk Metastasis Follow-up Metastatic Cancers</brief_title>
	<detailed_description>Whole-body MRI include diffusion booming technique . Numerous study demonstrate interest metastatic cancer . Breast cancer , especially hormone-sensitive one , osteophilic bone frequent metastatic site . Other site include lung , liver , pleura , distant lymph node , soft tissue central nervous system . Metastasis locate exclusively bones 30 % case . The commonly affected bone include axial skeleton , rich hematopoietic bone marrow : column , pelvis , skull , rib , clavicle , proximal part femur humerus . Five percent breast cancer directly metastatic 20 30 % localize breast cancer progress metastatic stage . This potentially affect large number patient , median survival 30 36 months.Patients bone metastases good survival rate others : 20 % 5 year . It therefore important use reliable reproducible examination monitor treatment response . Apart morphological criterion ( lesion size RECIST criterion ) , MRI provide quantitative functional criterion ( diffusion ADC value ) . According recent study , whole body MRI good PET/CT effective bone scintigraphy diagnosis bone metastases cancer breast prostate high metastatic risk . However , preliminary study limit heterogeneous cohort patient . Therefore , seem appropriate study performance whole body MRI pre-therapeutic assessment breast cancer high risk metastasis monitoring metastatic breast cancer .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Histological diagnosis breast carcinoma B5 Axillary lymph node punction C5 metastatic Performance status 0 2 . Ferromagnetic metallic foreign body ( pacemaker , implant cochlear , neurostimulator , ... ) Claustrophobia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Whole body MRI</keyword>
	<keyword>Breastcancer</keyword>
</DOC>